Renal and Cardiovascular Risk According to Tertiles of Urinary Albumin-to-Creatinine Ratio: The Adolescent Type 1 Diabetes Cardio-Renal Intervention Trial (AdDIT)
Journal article
Marcovecchio ML. et al, (2018), DIABETES CARE, 41, 1963 - 1969
Questioning the Associations of ω-3 Fatty Acid Supplement Use With Cardiovascular Disease Risks-Reply.
Journal article
Clarke RJ. et al, (2018), JAMA Cardiol
Effect of Vitamin D Supplementation on Markers of Vascular Function: A Systematic Review and Individual Participant Meta-Analysis.
Journal article
Beveridge LA. et al, (2018), J Am Heart Assoc, 7
Genomic Response to Vitamin D Supplementation in the Setting of a Randomized, Placebo-Controlled Trial.
Journal article
Berlanga-Taylor AJ. et al, (2018), EBioMedicine
Ezetimibe: Likely to Be Beneficial For All.
Journal article
Herrington WG. et al, (2018), Circulation, 137, 1583 - 1584
Associations of Omega-3 Fatty Acid Supplement Use With Cardiovascular Disease Risks: Meta-analysis of 10 Trials Involving 77 917 Individuals.
Journal article
Aung T. et al, (2018), JAMA Cardiol, 3, 225 - 234
Impact of Apolipoprotein(a) Isoform Size on Lipoprotein(a) Lowering in the HPS2-THRIVE Study.
Journal article
Parish S. et al, (2018), Circ Genom Precis Med, 11
Effects of Vitamin D on Blood Pressure, Arterial Stiffness, and Cardiac Function in Older People After 1 Year: BEST-D (Biochemical Efficacy and Safety Trial of Vitamin D).
Journal article
Clarke RJ. et al, (2017), Journal of the American Heart Association, 6
The Role of Emerging Risk Factors in Cardiovascular Outcomes.
Journal article
Lacey B. et al, (2017), Curr Atheroscler Rep, 19
LENS - a clinical trial embedded in routine clinical practice to reduce the burden of diabetic eye disease
Conference paper
Preiss D. et al, (2017), TRIALS, 18
Using optical character recognition for processing paper forms in a large randomised clinical trial
Conference paper
Murawska A. et al, (2017), TRIALS, 18
Telephone support for mail based recruitment and follow-up in a large randomized trial
Conference paper
Chen F. et al, (2017), TRIALS, 18
Factors influencing recruitment in large randomised trials
Conference paper
Edwards D. et al, (2017), TRIALS, 18
Safety and efficacy of statins reply
Journal article
Collins R. et al, (2017), LANCET, 389, 1099 - 1100
Optimum dose of vitamin D for disease prevention in older people: BEST-D trial of vitamin D in primary care.
Journal article
Hin H. et al, (2016), Osteoporos Int
Interpretation of the evidence for the efficacy and safety of statin therapy.
Journal article
Collins R. et al, (2016), Lancet (London, England)
Lessons from the controversy over statins - Authors' reply.
Journal article
Armitage J. et al, (2016), Lancet, 388, 2237 - 2238
The Effects of Vascular and Nonvascular Adverse Events and of Extended-Release Niacin with Laropiprant on Health and Healthcare Costs
Journal article
Mihaylova BN. et al, (2016), Circulation: Cardiovascular Quality and Outcomes
Cost-effective recruitment methods for a large randomised trial in people with diabetes: A Study of Cardiovascular Events iN Diabetes (ASCEND).
Journal article
Aung T. et al, (2016), Trials, 17, 286 - 286
Protocol for analyses of adverse event data from randomized controlled trials of statin therapy
Journal article
Reith C. et al, (2016), American Heart Journal, 176, 63 - 69